Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF
| Autor: | Chauffert, B. *, Feuvret, L., Bonnetain, F., Taillandier, L., Frappaz, D., Taillia, H., Schott, R., Honnorat, J., Fabbro, M., Tennevet, I., Ghiringhelli, F., Guillamo, J.S., Durando, X., Castera, D., Frenay, M., Campello, C., Dalban, C., Skrzypski, J., Chinot, O. |
|---|---|
| Zdroj: | In Annals of Oncology July 2014 25(7):1442-1447 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|